75 related articles for article (PubMed ID: 6818311)
1. [Relationship between circulating androgens and ovarian hyperstimulation syndrome in anovulatory patients treated with hMG-hCG].
Takahashi H; Inui Y; Mimura T; Kato H; Yamano S; Oono Y; Takeuchi S; Ezaki Y; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2163-71. PubMed ID: 6818311
[TBL] [Abstract][Full Text] [Related]
2. Androgenic response in anovulatory women during menotropins stimulation.
Skaf RA; Shelden R; Kemmann E
Obstet Gynecol; 1981 Dec; 58(6):714-9. PubMed ID: 6796920
[TBL] [Abstract][Full Text] [Related]
3. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
Hamori M; Zwirner M; Clédon P; Tinneberg HR
Int J Fertil; 1992; 37(3):171-5. PubMed ID: 1355764
[TBL] [Abstract][Full Text] [Related]
4. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
Notation AD; Tagatz GE; Steffes MW
Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
[TBL] [Abstract][Full Text] [Related]
5. Serial monitoring of serum estradiol and progesterone levels during the HMG-HCG therapy in sex anovulatory women.
Sakuragi N; Tanaka T; Fujimoto S; Ichinoe K
Int J Gynaecol Obstet; 1981 Mar; 19(1):53-6. PubMed ID: 6111497
[TBL] [Abstract][Full Text] [Related]
6. [Treatment and prevention of the ovarian hyperstimulation syndrome].
Morán C; Ortega E; Fiorelli S; Murillo A; Zárate A
Ginecol Obstet Mex; 1992 Jan; 60():4-7. PubMed ID: 1555790
[TBL] [Abstract][Full Text] [Related]
7. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
Kooguchi J; Uemura T; Shiojima Y; Iwasaki H
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):777-85. PubMed ID: 6787830
[TBL] [Abstract][Full Text] [Related]
8. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
9. [The change of plasma hormonal patterns following gonadotropin therapies (author's transl)].
Matsuoka M
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Feb; 34(2):143-52. PubMed ID: 6801159
[TBL] [Abstract][Full Text] [Related]
10. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
[TBL] [Abstract][Full Text] [Related]
11. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
Smitz J; Andersen AN; Devroey P; Arce JC;
Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring of follicles by ultrasonography during induction with HMG-HCG treatment--especially on the prevention of side effects].
Ishimaru T; Okamoto S; Kajimura H; Masuzaki H; Huang HJ; Fuchi T; Yamashita T; Imamura S; Imamichi S; Hata T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):721-9. PubMed ID: 3923140
[TBL] [Abstract][Full Text] [Related]
13. Elevtion of serum testosterone in ovarian hyperstimulation syndrome.
Schumert Z; Spitz I; Diamant Y; Polishuk WZ; Rabinowitz D
J Clin Endocrinol Metab; 1975 May; 40(5):889-92. PubMed ID: 1127095
[TBL] [Abstract][Full Text] [Related]
14. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
15. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
[TBL] [Abstract][Full Text] [Related]
16. [A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].
Kamata S
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):64-72. PubMed ID: 3081668
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
Tulandi T; McInnes RA; Arronet GH
Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
[TBL] [Abstract][Full Text] [Related]
18. Ovulation monitored by serum 17 beta-estradiol and ultrasound: differential ovarian response to human gonadotropins in various anovulatory states.
Padova G; Briguglia G; Tita P; Arpi ML; Munguira ME; Cafiso F; Cianci A; Ettore G; Pezzino V
Acta Eur Fertil; 1988; 19(5):283-6. PubMed ID: 3150888
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation.
Fanchin R; de Ziegler D; Taieb J; Olivennes F; Castracane VD; Frydman R
Fertil Steril; 2000 Feb; 73(2):275-9. PubMed ID: 10685528
[TBL] [Abstract][Full Text] [Related]
20. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles.
Blankstein J; Shalev J; Saadon T; Kukia EE; Rabinovici J; Pariente C; Lunenfeld B; Serr DM; Mashiach S
Fertil Steril; 1987 Apr; 47(4):597-602. PubMed ID: 3106098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
